Updated Jul 16, 2026 · Last SEC filing 2026-06-05
PRECISION BIOSCIENCES INC (DTIL) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-05. 5 Form 8-K material event filings were reported by DTIL in the last 90 days. InsiderAlpha tracks every DTIL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001357874 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Latest Form 4 filing | 2026-06-05 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Frankel Stanley | Director | M — Option exercise | 21.0K | — | — | SEC | |
| Buehler Kevin | Director | M — Option exercise | 21.0K | — | — | SEC | |
| Brown Melinda | Director | M — Option exercise | 21.0K | — | — | SEC | |
| Pire Shari Lisa | Director | M — Option exercise | 21.0K | — | — | SEC | |
| Germano Geno J | Director | M — Option exercise | 21.0K | — | — | SEC | |
| Kelly John Alexander | Chief Financial Officer | S — Open-market sale [10b5-1] | 8.1K | $3.84 | $31K | SEC | |
| Scimeca Dario | General Counsel and Secretary | S — Open-market sale [10b5-1] | 4.9K | $3.84 | $19K | SEC | |
| SMITH J. JEFFERSON | Chief Research Officer | S — Open-market sale [10b5-1] | 4.9K | $3.84 | $19K | SEC | |
| Amoroso Michael | President and CEO | S — Open-market sale [10b5-1] | 20.6K | $3.84 | $79K | SEC | |
| SMITH J. JEFFERSON | Chief Research Officer | M — Option exercise [10b5-1] | 16.7K | $0.00 | — | SEC | |
| Amoroso Michael | President and CEO | M — Option exercise [10b5-1] | 67.8K | $0.00 | — | SEC | |
| Scimeca Dario | General Counsel and Secretary | M — Option exercise [10b5-1] | 16.7K | $0.00 | — | SEC | |
| Kelly John Alexander | Chief Financial Officer | M — Option exercise [10b5-1] | 27.6K | $0.00 | — | SEC | |
| Amoroso Michael | President and CEO | S — Open-market sale [10b5-1] | 34.8K | $4.17 | $145K | SEC | |
| SMITH J. JEFFERSON | Chief Research Officer | S — Open-market sale [10b5-1] | 10.2K | $4.03 | $41K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for PRECISION BIOSCIENCES INC (DTIL). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Frankel Stanley | 3 | — |
| Buehler Kevin | 3 | — |
| Germano Geno J | 3 | — |
| Pire Shari Lisa | 3 | — |
| Brown Melinda | 3 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in DTIL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live DTIL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.